Literature DB >> 20824023

Endocrine Therapy - What Else?

Christian Marth1.   

Abstract

Year:  2008        PMID: 20824023      PMCID: PMC2931100          DOI: 10.1159/000160910

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  7 in total

1.  Estrogen-receptor interactions in target tissues.

Authors:  E V Jensen; E R Desombre; D J Hurst; T Kawashima; P W Jungblut
Journal:  Arch Anat Microsc Morphol Exp       Date:  1967

2.  Dose-response effect of adjuvant chemotherapy in breast cancer.

Authors:  G Bonadonna; P Valagussa
Journal:  N Engl J Med       Date:  1981-01-01       Impact factor: 91.245

Review 3.  Adherence to therapy with oral antineoplastic agents.

Authors:  Ann H Partridge; Jerry Avorn; Philip S Wang; Eric P Winer
Journal:  J Natl Cancer Inst       Date:  2002-05-01       Impact factor: 13.506

4.  Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

Authors:  Ann H Partridge; Philip S Wang; Eric P Winer; Jerry Avorn
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

Review 5.  Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

Authors:  Janice M Walshe; Neelima Denduluri; Sandra M Swain
Journal:  J Clin Oncol       Date:  2006-11-27       Impact factor: 44.544

6.  Adjuvant Endocrine Therapy in Premenopausal Patients.

Authors:  Michael Gnant
Journal:  Breast Care (Basel)       Date:  2008-10-17       Impact factor: 2.860

7.  Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer.

Authors:  Christoph Mundhenke; Christian Schem; Walter Jonat
Journal:  Breast Care (Basel)       Date:  2008-10-21       Impact factor: 2.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.